What's new

Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 5, Status: Authorised

Jun 2, 2025 - 15:00
 0
Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Xofluza, baloxavir marboxil, Date of authorisation: 07/01/2021, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab,...

Next Article

EMA roundtable with stakeholders on the 20th anniversary of the SME Regulation, ...

Related Posts

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

European Shortages Monitoring Platform (ESMP) User guid...

May 13, 2025  0

Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0